Aya Haggiagi, MD is an assistant professor of neurology at CUIMC, in the Division of Neuro-Oncology. Dr. Haggiagi is board certified in Neurology and Neuro-Oncology. She graduated with highest honors from the University of Al-Fateh School of Medicine in Tripoli, Libya. She subsequently completed a postdoctoral research fellowship in the Department of Pathology and Cell Biology at Columbia, under the mentorship of Dr. Michael Shelanski, where her research focused on biochemical and genetic changes in neurofibrillary tangle predominant dementia. Dr. Haggiagi then pursued her medicine internship training at Westchester Medical Center, followed by neurology residency at NewYork-Presbyterian/Columbia University Irving Medical Center. After residency, she completed a two-year fellowship in Neuro-Oncology at Memorial Sloan Kettering Cancer Center.
Dr. Haggiagi was an attending physician and an investigator at Memorial Sloan Kettering Cancer Center prior to returning to NYP/CUIMC. She is the recipient of the Society for Neuro-Oncology 2017 Best Abstract Award. Her research interests include the development of clinical trials, precision medicine, and neurologic complications of immunotherapy.
|Brain Tumors||[ CLOSED ] ANG1005 in Leptomeningeal Disease From Breast Cancer (ANGLeD)|
|Brain Tumors||[ CLOSED ] Nivolumab and Multi-fraction Stereotactic Radiosurgery (Non-Surgical Radiation Therapy) in Treating Participants With Meningioma|
|Brain Tumors||Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary Central Nervous System (CNS) Lymphoma|
|Brain Cancer||Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary Central Nervous System (CNS) Lymphoma|